Industrifonden has lead a SEK 25m funding round for Aprea AB, a Swedish developer of drugs against cancer. Existing investors, Karolinska Development, Östersjöstiftelsen (The Baltic Foundation) and Praktikerinvest have also participated in the investment round.
Fund, which has already been invested in at least one transaction, has a €1bn target
Pechel, via Pechel IV, and the co-investment team of Omnes back the French IT services firm
Connection Capital provided £6.7m to support the buyout of the business in 2017
Temasek previously led a £7m investment for the technology developer in 2016